menu
    • menu

    Company profile for CSL Behring

    NEW Drugs in Dev: 63
    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    CSL Behring is a global leader in the plasma protein biotherapeutics industry. We research, develop, manufacture and market biotherapies that are used to treat serious and rare conditions. Users of our therapies rely on them for their quality of life and, in many cases, for life itself. Our commitment to saving lives and improving the quality of life for people with serious and rare conditions is evident in everything we do. ...
    CSL Behring is a global leader in the plasma protein biotherapeutics industry. We research, develop, manufacture and market biotherapies that are used to treat serious and rare conditions. Users of our therapies rely on them for their quality of life and, in many cases, for life itself. Our commitment to saving lives and improving the quality of life for people with serious and rare conditions is evident in everything we do. Whether we are manufacturing and marketing safe and effective products or researching and developing innovative biotherapies, we are first and foremost focused on fulfilling our customers’ needs.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    CSL BehringUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    HQ; 1020 First AvenueA
    Telephone
    Telephone
    +1 610-878-4000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.cslbehring.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    CSL sinks to Nine-Year Low On Revenue Warning, $5B write-down
    CSL sinks to Nine-Year Low On Revenue Warning, $5B write-down

    11 May 2026

    // ENDPOINTS

    https://endpoints.news/csl-sinks-to-nine-year-low-on-revenue-warning-5b-write-down/

    ENDPOINTS
    11 May 2026
    Share Share
    CSL adds warning to Flucelvax label
    CSL adds warning to Flucelvax label

    25 Mar 2026

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/fierce-pharma-regulatory-tracker-2026

    FIERCE PHARMA
    25 Mar 2026
    Share Share
    CSL's Hemgenix In 'Temporary Global Stockout,' Company Says
    CSL's Hemgenix In 'Temporary Global Stockout,' Company Says

    19 Mar 2026

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/csls-hemgenix-manufacturing-related-temporary-global-stockout-sparking-treatment-delays

    FIERCE PHARMA
    19 Mar 2026
    Share Share
    CSL firms up details on $1.5B US plasma-based medicines plant
    CSL firms up details on $1.5B US plasma-based medicines plant

    11 Mar 2026

    // FIERCE PHARMA

    https://www.fiercepharma.com/manufacturing/csl-telegraphs-300-new-hires-2031-completion-target-it-breaks-ground-15b-plasma-based

    FIERCE PHARMA
    11 Mar 2026
    Share Share
    CSL Signs Licensing Deal with Eli Lilly for Clazakizumab
    CSL Signs Licensing Deal with Eli Lilly for Clazakizumab

    17 Feb 2026

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/csl-signs-licensing-deal-with-eli-lilly-clazakizumab-treat-kidney-disease-2026-02-17/

    REUTERS
    17 Feb 2026
    Share Share
    CSL Details Sales Slide Behind Recent Leadership Transition
    CSL Details Sales Slide Behind Recent Leadership Transition

    12 Feb 2026

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/csls-bleak-earnings-report-helps-explain-why-it-made-ceo-switch

    FIERCE PHARMA
    12 Feb 2026
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact CSL Behring and get a quotation

    CSL Behring is a supplier offers 2 products (APIs, Excipients or Intermediates).

    Find Water bulk with CEP offered by CSL Behring

    Find ISCOMATRIX ADJUVANT bulk offered by CSL Behring

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search